Teriparatide Bests Risedronate for Fracture Prevention in Severe Osteoporosis

Daily subcutaneous teriparatide prevents fractures more effectively than weekly oral risedronate, finds an international, industry-conducted study in the Lancet. Over 1300 postmenopausal women with...
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news